Ketamine Suppresses Intestinal TLR4 Expression and NF-kappaB Activity in Lipopolysaccharide-Treated Rats.

Min Yu,Danbing Shao,Jianjun Yang,Shangwu Feng,Jianguo Xu
2006-01-01
Abstract:Aim To investigate whether ketamine suppresses lipopolysaccharide (LPS)-induced increase in Toll-like receptor 4 (TLR4) expression and nuclear factor-kappa B (NF-kappa B) activity in the intestines of rats.Methods Six groups of rats received one of the following: normal saline control, LPS (5 mg/kg) plus saline, LPS (5 mg/kg) plus ketamine (0.5 mg/kg), LPS (5 mg/kg) plus ketaminc (2-5 mg/kg), LPS (5 mg/kg) plus ketamine (10 mg/kg), or ketamine (10 mg/kg) alone. Intestinal TLR4 mRNA expression was analyzed by reverse transcription polymerase chain reaction (RT-PCR), and NF-kappa B activity was tested by electrophoretic mobility shift assay (EMSA) 1, 3, or 5 hours after the LPS injection.Results Lipopolysaccharide increased TLR4 expression and NF-kappa B activity in the intestines of rats. Ketamine at the dosage of 0.5, 2.5, and 10 mg/ kg suppressed the LPS-induced increase in TLR4 expression and NF-kappa B activity. Ketamine alone had no effect. Conclusion The study demonstrated that ketaminc inhibits NF-kappa B activation in the intestines of LPS-treated rats, possibly by suppressing TLR4 expression.Conclusion The study demonstrated that ketamine inhibits NF-kappa B activation in the intestines of LPS-treated rats, possibly by suppressing TLR4 expression.
What problem does this paper attempt to address?